Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response

Figure 1 Receiver operating characteristic curve comparing end of treatment response, biochemical response, stage of fibrosis with sustained viral response. Receiver operating characteristic curve showing comparison between end of treatment response [area under curves (AUC) 0.997, 95% CI: 0.99-1.004], biochemical response (AUC 0.744, 95% CI: 0.67-0.81), stage of fibrosis (AUC 0.625, 95% CI: 0.54-0.70). The best predictor was end of treatment response at 99.7% (P = 0.001), followed by biochemical response 74.4% (P = 0.001) and stage of fibrosis 62.5% (P = 0.002).